This is the authors' abstract. We don't add key points for this paper.
THC:CBD oromucosal spray provided consistent relief with good tolerability in MS spasticity patients irrespective of their antispasticity pre-treatment history.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Haupts et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: